IDORSIA
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
IDORSIA
Industry:
Biotechnology Health Care
Founded:
2017-06-01
Status:
Active
Contact:
41 58 844 00 00
Email Addresses:
[email protected]
Total Funding:
1.44 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Apache
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Swords Labs
Bristol-Myers Squibb is a biopharma company that works to discover, and deliver innovative medicines that help patients fight disease.
TransGenex Nanobiotech
TransGenex Nanobiotech is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-23 | Vaxxilon | Vaxxilon acquired by Idorsia | N/A |
Investors List
CARB-X
CARB-X investment in Grant - Idorsia
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-20 | Santhera Pharmaceuticals | Idorsia investment in Post-IPO Equity - Santhera Pharmaceuticals | 20 M CHF |
More informations about "Idorsia"
Idorsia | About Idorsia
Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 4123 Allschwil Switzerland +41 58 844 00 00. ... One of the main reasons to to become a member of the Idorsia organization and stay with the company is the exciting opportunity to …See details»
Idorsia - Wikipedia
After Actelion was bought by Johnson & Johnson in 2017, Idorsia was spun out into a new company and started operating on the same campus where Actelion was founded under the leadership of Actelion founders Jean-Paul Clozel as CEO and Martine Clozel as CSO. The company expects to be profitable in 2025. In July 2023 due to a disappointing sales ramp-up of the recently approved sleep drug daridorexantSee details»
How we started - Idorsia
This message is constantly repeated at all levels of Idorsia, and our teams are well aware that they are expected to achieve ambitious targets, to work in an ethical manner, and to keep a keen eye on the bottom line. We have a great …See details»
About us - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Strategic priorities - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Strategy - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social performance. People. People. It’s the Idorsia team’s …See details»
People and society - Idorsia
Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 4123 Allschwil Switzerland +41 58 844 00 00. ... We take an integrated approach to rewards and talent management, designed to build …See details»
Idorsia | Research & Development
General Contact: Idorsia Pharmaceuticals US Inc. One Radnor Corporate Center, Suite 101 100 Matsonford Rd Radnor, PA 19087 (888) 971-7050. If you wish to get in touch with us, please click Next and contact us via the contact form.See details»
Idorsia - Crunchbase Investor Profile & Investments
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a …See details»
Idorsia expands its commercialization partnership with Syneos …
Idorsia Ltd (SIX: IDIA), a leading Swiss biopharmaceutical company, and Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today …See details»
About us - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Our Innovation - Idorsia
Idorsia aims to deliver new products with the potential to significantly change the treatment options in their target diseases. We want to bring new perspectives to the discovery, …See details»
Grants & Sponsorships Global - Powered By Science | Idorsia …
An arrangement where Idorsia provides funds to an organization in return for enabling Idorsia to promote its company name to an audience or to maintain a booth, in accordance with local …See details»
News - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Serving patients - Idorsia
Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 4123 Allschwil Switzerland +41 58 844 00 00. Please get in touch with us via the contact form by clicking "Next". ... The request must be …See details»
Idorsia | Responsibilities
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Idorsia | Responsibilities
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Idorsia | Corporate Reports
Jul 25, 2024 The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early …See details»
Grants & Sponsorships US - Powered By Science - Idorsia
An arrangement where Idorsia provides funds to an organization in return for enabling Idorsia to promote its company name to an audience or to maintain a booth, in accordance with local …See details»